Sophie has written extensively in the field of outcomes research and has published in her own right. MedLink MedLink is a behavioral intervention technology 30 digital support system intended to enhance antidepressant treatment processes and outcomes in primary care, targeting the failure points described in Figure 1. Search by condition or funding sponsor. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. All patients were continuing to take their medications at week 4.
Subsequent weeks focus on common depression management strategies, such as increasing positive activities Week 2 , managing cognitive biases Week 3 and improving social support Week 4. Finally, the current study cannot tell us if any of the components of the intervention are particularly effective, if some are useful, or if each component is serving the specific intended function, such as increasing knowledge or motivation. Feedback interviews revealed that patients were generally neutral about the assessments. Electronic medication packaging devices and medication adherence: One patient reported having difficulty getting the pill bottle through airport security. Depression imposes a very high societal burden in terms of cost, morbidity, suffering, and mortality [ 2 ], and is a leading cause of disability worldwide [ 3 ].
Am J Psychiatry ; The first focus group explored the data elements that they would require, and how those data should be provided.
American College of Chest Physicians evidence-based clinical practice researhc 9th edition June Support Center Support Center. The limitations not withstanding, the present study provides initial evidence for MedLink.
MedLink was designed to be very simple and efficient to ;aper. Physician ;aper – American Board of Medical Specialties Verify the board certification status, location by city and state, and specialty of any physician certified by one or more of the 24 Member Boards of the American Board of Medical Specialties.
Thus, the researcu and usefulness of the system with missing information e. Given the number of patient factors driving non-adherence, and the lack of communication between physicians and patients, and the failure of physicians to optimize the treatment regimen, it is not surprising that adherence rates are so low and treatment outcomes are so poor.
Journal List Digit Health v. Several of the contacts occurred through the patient portal, indicating that patients were contacting their care providers, based on reports and recommendations provided to them. Given the prevalence of depression and the volume of patients that PCPs are expected to see, even this relatively small individual burden could end up being a substantial burden across an entire caseload.
Psychiatr Serv ; The aim of this study was to evaluate the feasibility of a systemic digital intervention, MedLink, which comprehensively and systematically addresses modifiable patient, physician and communication failure points during the early acute phase of treatment for depression in primary care.
The use data indicated that patients used the system, for the most part consistently, over the eight weeks they were beginning their antidepressant papwr, when they are establishing their medication-taking routine and the risk of non-adherence and discontinuation is highest.
MedLink MedLink is a behavioral intervention technology 30 digital support system intended to enhance antidepressant treatment processes and outcomes in primary care, targeting the failure points described in Figure 1. Medlin was decided that, for this early field trial, paper reports would be provided to physicians.
Improving adherence in mood disorders: All patient-facing elements of MedLink were subjected to in-lab usability testing with 23 patients taking medications 12 with MDD taking antidepressants and 11 without MDD, some taking an antidepressant and some taking a non-psychiatric medication. Treating major depression in primary care practice: The 15 guidelines provided on this site offer a comprehensive diagnostic tool to help both determine stroke severity and appropriate treatment.
IRSA; January ; 11 pages.
STC Usability Newsletter ; 8. J Gen Intern Med. All participants completed all assessments in the eight-week trial. J Clin Psychiatry ; 67 Suppl.
Meet The Team – Med Link | Med Link
Search by condition or funding sponsor. Of the 32 assessments, 29 Summary of evidence-based guideline update: Lessons written by authors D. In addition to the full text guideline, this guideline also has an associated Medlijk Summary, Patient Summary, and Case Study. This study supports the use of a comprehensive, systemic approach to mHealth solutions to enhance processes of care for depression by general medicine physicians.
Meet our team of professional medical writers and project managers
The one participant who discontinued reported that she did so due to researcj effects. A cellularly enabled pill bottle monitors medication adherence. The FIBSER consists of three items measuring the overall frequency, severity and impact on functioning of all side effects.
As noted above, physicians were concerned that the PHQ-9 item assessing suicidal ideation is too non-specific to be actionable and therefore would frequently trigger needless medlimk to the patient, significantly increasing burden on the clinic staff and the patient.
While the severity of side effects frequently declines over time, patients are usually not provided with information on how to manage them.